Epitomics' Acquisition

Epitomics was acquired by Abcam on March 07, 2012.

Epitomics is a maker and commercial supplier of monoclonal antibodies for human therapeutics development. The company offers reagents, diagnostics, and contract research to leading scientific research…

Articles about Epitomics' Acquisition: